Reply to the Comment on ‘Nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Adenocarcinoma After Folfirinox Failure: An AGEO Prospective Multicentre Cohort’
British Journal of Cancer - United Kingdom
doi 10.1038/bjc.2016.70
Full Text
Open PDFAbstract
Available in full text
Date
April 28, 2016
Authors
Publisher
Springer Science and Business Media LLC